United States
Medizinprodukt-Marktintelligenz für United States. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Neueste Signale
Philips enhances MRI machines with Disney characters to reduce children's anxiety during scans.
Procept BioRobotics has obtained a second FDA IDE for Aquablation therapy and completed WATER IV study enrollment.
Less than 10% of patients adhere to rehab routines, presenting a significant market opportunity for medical technology.
Medical Components, Inc. has registered Medcomp and Jet Medical Repair Kits as Class IIa devices in EUDAMED.
A new framework for X-ray grating interferometry improves dark-field imaging by mitigating beam hardening artifacts.
MTD Micro Molding has appointed Chad Nikel as CEO to lead growth in precision micro manufacturing.
Boston Scientific's CEO emphasizes the importance of company culture in driving success in the medical device sector.
Dukane's ultrasonic welding technology aids in producing wearable diabetes management devices.
J&J's Shockwave C2 Aero IVL device offers faster treatment for complex calcifications, FDA approved in June 2025.
Brian Miller discusses insights from Intuitive and Sovato's plans for telesurgery development.
Edwards Lifesciences reported double-digit pay increases for executives and median employees, reflecting its growth.
Sentante's endovascular robotics system received FDA Breakthrough Device designation and TAP acceptance in February 2026.
Medtronic has initiated a five-year post-approval study for its Altaviva neurostimulator following its recent approval.
Tecomet and Orchid have merged to create a global manufacturing platform for medical devices.
Zimmer Biomet announced a double-digit pay increase for its median employee and disclosed executive compensation.
E&L testing in medical devices should be integrated earlier in development to avoid late-stage challenges.
Nissha Medical Technologies has started construction on a new 50,000 sq ft facility in Wisconsin to expand micro molding operations.
Mayo Clinic is using New Phase's electromagnetic induction system for cancer treatment in a clinical trial.
The FDA warns of a neurosurgical device shortage linked to Medline's Class 2 recall, potentially lasting until 2026.
The FDA has initiated a pilot program for one-day inspections of low-risk facilities using AI for assessment.